$24.81
0.94% today
NYSE, Apr 01, 06:13 pm CET
ISIN
US2289031005
Symbol
AORT

CryoLife Stock price

$24.58
-0.83 3.27% 1M
-2.04 7.66% 6M
-4.01 14.03% YTD
+3.39 16.00% 1Y
+3.20 14.97% 3Y
+7.66 45.27% 5Y
+14.21 137.03% 10Y
NYSE, Closing price Mon, Mar 31 2025
+0.33 1.36%
ISIN
US2289031005
Symbol
AORT
Sector

Key metrics

Market capitalization $1.03b
Enterprise Value $1.34b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 121.48
EV/Sales (TTM) EV/Sales 3.45
P/S ratio (TTM) P/S ratio 2.66
P/B ratio (TTM) P/B ratio 3.73
Revenue growth (TTM) Revenue growth 9.75%
Revenue (TTM) Revenue $388.54m
EBIT (operating result TTM) EBIT $62.57m
Free Cash Flow (TTM) Free Cash Flow $11.05m
Cash position $53.46m
EPS (TTM) EPS $-0.32
P/E forward 1,437.43
P/S forward 2.44
EV/Sales forward 3.17
Short interest 10.60%
Show more

Is CryoLife a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

CryoLife Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a CryoLife forecast:

6x Buy
100%

Analyst Opinions

6 Analysts have issued a CryoLife forecast:

Buy
100%

Financial data from CryoLife

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
389 389
10% 10%
100%
- Direct Costs 156 156
11% 11%
40%
232 232
9% 9%
60%
- Selling and Administrative Expenses 117 117
25% 25%
30%
- Research and Development Expense 28 28
1% 1%
7%
87 87
205% 205%
22%
- Depreciation and Amortization 24 24
5% 5%
6%
EBIT (Operating Income) EBIT 63 63
1,068% 1,068%
16%
Net Profit -13 -13
56% 56%
-3%

In millions USD.

Don't miss a Thing! We will send you all news about CryoLife directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CryoLife Stock News

Neutral
PRNewsWire
28 days ago
ATLANTA , March 4, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate virtually at the upcoming Oppenheimer 35th Annual Healthcare MedTech & Services Conference. The Company's virtual fireside chat is scheduled to begin at 10:40 a.m.

Company Profile

CryoLife, Inc. engages in the manufacture, process and distribution of medical devices. It operates through the following segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of BioGlue; JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PerClot and PhotoFix. The Preservation Services segment focuses on external services revenues from the preservation of cardiac and vascular tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.

Head office United States
CEO James Mackin
Employees 1,600
Founded 1984
Website www.artivion.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today